DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001060:Aporphines / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D004232:Diuretics; D004298:Dopamine / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D048288:Imidazolines; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011954:Receptors, Dopamine / Q000187:drug effects*; D015016:Yohimbine / Q000494:pharmacology
D001060:Aporphines; D002395:Catecholamines; D004232:Diuretics; D007093:Imidazoles; D048288:Imidazolines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D015016:Yohimbine; D005665:Furosemide; C011775:(3,4-dihydroxyphenylamino)-2-imidazoline; D001058:Apomorphine; D004298:Dopamine; D010646:Phentolamine